CS logo
small CS logo
IPS Centro Cientifico Asistencial S.A.S

Barranquilla, Atlántico, Colombia
Medical laboratory in Barranquilla
Cra. 45 #85-49, Barranquilla, Atlántico

About IPS Centro Cientifico Asistencial S.A.S


"La IPS CENTRO CIENTIFICO ASITENCIAL S.A.S ofrece servicios de salud de baja y mediana complejidad, orientados al fomento de la salud, la prevención primaria y secundaria, tratamiento y seguimiento de enfermedades crónicas no transmisibles, en el contexto de la conducción de estudios clínicos, bajo el rigor de los preceptos éticos y científicos de las Buenas Prácticas Clínicas."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Boehringer Ingelheim
2
Total Rows: 2

Clinical Trials at IPS Centro Cientifico Asistencial S.A.S


During the past decade, IPS Centro Cientifico Asistencial S.A.S conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111100110011000011110011Started TrialsCompleted Trails20172018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "IPS Centro Cientifico Asistencial S.A.S" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 3Bayer: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Canadian VIGOUR Centre: 1Canadian VIGOUR Centre: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1

Clinical Trials Conditions at IPS Centro Cientifico Asistencial S.A.S


According to Clinical.Site data, the most researched conditions in "IPS Centro Cientifico Asistencial S.A.S" are "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "IPS Centro Cientifico Asistencial S.A.S" in a lesser frequency.

Clinical Trials Intervention Types at IPS Centro Cientifico Asistencial S.A.S


Most popular intervention types in "IPS Centro Cientifico Asistencial S.A.S" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at IPS Centro Cientifico Asistencial S.A.S


The vast majority of trials in "IPS Centro Cientifico Asistencial S.A.S" are 5 trials for "All" genders.

Clinical Trials Status at IPS Centro Cientifico Asistencial S.A.S


Currently, there are NaN active trials in "IPS Centro Cientifico Asistencial S.A.S". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in IPS Centro Cientifico Asistencial S.A.S, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IPS Centro Cientifico Asistencial S.A.S, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1